Cibc Asset Management Inc Spectrum Pharmaceuticals Inc Transaction History

Cibc Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$2.15 - $3.82 $23,671 - $42,058	-11,010 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.9 - $4.09 $1,049 - $1,480	362 Added 3.4%	11,010 $36,000
Q4 2020 Feb 03, 2021	SELL	$3.38 - $5.14 $1,419 - $2,158	-420 Reduced 3.79%	10,648 $36,000
Q3 2020 Nov 05, 2020	BUY	$2.99 - $4.9 $343 - $563	115 Added 1.05%	11,068 $45,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $38,335 - $113,363	10,953 New	10,953 $40,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.